派格生物医药-B(02565)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02565 派格生物医药-B

未开盘 12-17 16:08:10

64.150

-0.750

-1.16%

最高65.000	最低63.150	成交量20.15万
今开65.000	昨收64.900	日振幅2.85%
总市值247.62亿	流通市值179.08亿	总股本3.86亿
成交额1,298万	换手率0.07%	流通股本2.79亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02565","market":"HK","secType":"STK","nameCN":"派格生物医药-B","latestPrice":64.15,"timestamp":1765958890008,"preClose":64.9,"halted":0,"volume":201500,"delay":0,"floatShares":279164339,"shares":386000000,"eps":-0.8535238402558397,"marketStatus":"未开盘","change":-0.75,"latestTime":"12-17 16:08:10","open":65,"high":65,"low":63.15,"amount":12975000,"amplitude":0.028505,"askPrice":64.15,"askSize":1000,"bidPrice":63.65,"bidSize":1500,"shortable":3,"etf":0,"ttmEps":-0.6640367000420175,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766021400000},"marketStatusCode":0,"adr":0,"listingDate":1748275200000,"exchange":"SEHK","adjPreClose":64.9,"openAndCloseTimeList":[[1765935000000,1765944000000],[1765947600000,1765958400000]],"volumeRatio":0.7013574657459921,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02565","defaultTab":"news","newsList":[{"id":"2592912635","title":"每日卖空追踪 | 派格生物医药-B 12月17日卖空量成交500股，卖空比例为0.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592912635","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592912635?lang=zh_cn&edition=full","pubTime":"2025-12-17 16:30","pubTimestamp":1765960231,"startTime":"0","endTime":"0","summary":"派格生物医药-B北京时间12月17日，跌1.16%，卖空量成交500股，较上一交易日减少93.75%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217163508a45613b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217163508a45613b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02565","BK1161"],"gpt_icon":0},{"id":"2591676206","title":"同仁堂回应磷虾油涉嫌造假；复星医药14.12亿元收购绿谷医药","url":"https://stock-news.laohu8.com/highlight/detail?id=2591676206","media":"21世纪经济报道","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591676206?lang=zh_cn&edition=full","pubTime":"2025-12-16 07:34","pubTimestamp":1765841653,"startTime":"0","endTime":"0","summary":"资本市场复星医药：控股子公司拟出资14.12亿元投资绿谷医药12月15日，复星医药公告称，公司控股子公司复星医药产业拟出资共计14.12亿元投资绿谷医药，包括受让部分股权和认缴新增注册资本。完成后，公司将通过复星医药产业及SPV合计持有绿谷医药53%的股权。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216073706a6a6ce59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216073706a6a6ce59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00867","02565","BK1593","09939","02196","BK1574","BK1191","BK1161","BK1515"],"gpt_icon":0},{"id":"2591676795","title":"每日卖空追踪 | 派格生物医药-B 12月15日卖空量成交500股，卖空比例为0.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591676795","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591676795?lang=zh_cn&edition=full","pubTime":"2025-12-15 16:30","pubTimestamp":1765787430,"startTime":"0","endTime":"0","summary":"派格生物医药-B北京时间12月15日，涨0.69%，卖空量成交500股，较上一交易日减少90.91%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251215163458a44d41a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251215163458a44d41a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02565","BK1161"],"gpt_icon":0},{"id":"2591369356","title":"重磅利好公告解读：派格生物-B（02565）基石延长的“定心丸”与募资成功的“冲锋号","url":"https://stock-news.laohu8.com/highlight/detail?id=2591369356","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591369356?lang=zh_cn&edition=full","pubTime":"2025-12-15 08:57","pubTimestamp":1765760233,"startTime":"0","endTime":"0","summary":"近日，派格生物-B发布了两则新公告，同时传递出了“坚定”与“进取”两种温度。“定心丸”——基石投资人为何“一延再延”?派格生物计划以每股58.41港元配售新股，募资净额近3亿港元。对于派格生物而言，上市只是拿到了入场券。派格生物的这声“冲锋号”与这颗“定心丸”，或许正是其下一段航程的开始。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1381328.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["02565","BK1161"],"gpt_icon":0},{"id":"2591660659","title":"派格生物医药-B(02565.HK)：基石投资者作出第二次自愿延长禁售期","url":"https://stock-news.laohu8.com/highlight/detail?id=2591660659","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591660659?lang=zh_cn&edition=full","pubTime":"2025-12-15 07:37","pubTimestamp":1765755421,"startTime":"0","endTime":"0","summary":"格隆汇12月15日丨派格生物医药-B(02565.HK)发布公告，近日，公司接获基石投资者的通知，据此，基石投资者同意自原禁售期(经第一次禁售延长予以延长)届满日期起至2026年4月30日不会以任何方式减持任何相关H股(“第二次禁售延长”)。公司认为，第二次禁售延长表明基石投资者基于公司对推进技术方面的研发能力及在重大临床里程碑方面取得的重大进展，对公司的未来前景充满信心。基石投资者亦将持续审阅公司业绩，且或会基于实时发展及所实现的里程碑，考虑进一步延长禁售期。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20251215/31864713.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["161726","02565","399441","BK1161"],"gpt_icon":0},{"id":"2591282661","title":"派格生物：通过一般授权配售新H股募资约3.0亿港元研发平台建设及业务拓展","url":"https://stock-news.laohu8.com/highlight/detail?id=2591282661","media":"新浪财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591282661?lang=zh_cn&edition=full","pubTime":"2025-12-14 20:20","pubTimestamp":1765714818,"startTime":"0","endTime":"0","summary":"来源：新浪港股-好仓工作室2025年12月12日，派格生物公告称，通过一般授权以配售新H股方式融资，其中配售新H股发行5,136,000股，募集总额约3.0亿港元；扣除费用后净得约2.96亿港元。配售股份占现有已发行股本约1.33%，完成后占扩大股本约1.31%。派格生物是一家专注于慢性疾病创新疗法研发的生物技术公司，主要开发肽类及小分子药物。本次发行根据股东大会授予的一般授权实施，预计于2025年12月22日完成。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251214202535a6a130d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251214202535a6a130d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02565","BK1161"],"gpt_icon":0},{"id":"2591663104","title":"派格生物医药-B(02565)拟折让10%配售合共513.6万股配售股份 净筹约2.96亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2591663104","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591663104?lang=zh_cn&edition=full","pubTime":"2025-12-14 19:35","pubTimestamp":1765712100,"startTime":"0","endTime":"0","summary":"智通财经APP讯，派格生物医药-B 发布公告，于2025年12月12日，本公司与联席配售代理订立配售协议，据此，本公司已有条件同意透过联席配售代理按尽力基准以每股配售股份58.41港元的价格向不少于六名承配人配售合共513.6万股配售股份，该等配售股份将由本公司根据一般授权按配售协议所载条款及条件发行。假设所有配售股份获悉数配售，配售的估计所得款项总额及所得款项净额将分别为约3亿港元及约2.96亿港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1381270.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["161726","399441","BK1161","02565"],"gpt_icon":0},{"id":"2590632548","title":"每日卖空追踪 | 派格生物医药-B 12月11日卖空量成交1000股，卖空比例为0.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590632548","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590632548?lang=zh_cn&edition=full","pubTime":"2025-12-11 16:30","pubTimestamp":1765441830,"startTime":"0","endTime":"0","summary":"派格生物医药-B北京时间12月11日，涨0.31%，卖空量成交1000股，较上一交易日减少75%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251211163525a441fca1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251211163525a441fca1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02565","BK1161"],"gpt_icon":0},{"id":"1145888957","title":"一周港股牛熊榜 | 次新股量化派、云迹大涨40%以上；五矿资源飙25%持续新高；重塑能源面临解禁大跌15%；大牛股派格生物本周回落12%","url":"https://stock-news.laohu8.com/highlight/detail?id=1145888957","media":"老虎资讯综合","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145888957?lang=zh_cn&edition=full","pubTime":"2025-12-05 18:40","pubTimestamp":1764931217,"startTime":"0","endTime":"0","summary":"值得注意的是，云迹在中国机器人服务智能体市场处于领先地位。于2024年，公司以6.3%的国内收入份额位居该市场第一。五矿资源 +25.57%得益于大宗商品特别是铜价格的持续上涨，五矿资源股价持续创新高。而大摩表示，应用仍是AI投资的首选，重申对腾讯控股、阿里巴巴和美图公司的增持评级。派格生物医药-B -12.33%大牛股派格生物医药本周出现回落。","market":"hk","thumbnail":"https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00800","02565","00376","02685","02788","01138","02670","01357","02570","01208"],"gpt_icon":1},{"id":"2588049493","title":"每日卖空追踪 | 派格生物医药-B 12月03日卖空量成交1万股，卖空比例为3.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588049493","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588049493?lang=zh_cn&edition=full","pubTime":"2025-12-03 16:30","pubTimestamp":1764750628,"startTime":"0","endTime":"0","summary":"派格生物医药-B北京时间12月03日，涨0.55%，卖空量成交1万股，较上一交易日减少87.65%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203163446978d7ba8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203163446978d7ba8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02565"],"gpt_icon":0},{"id":"2587765920","title":"派格生物：向证监会提交H股全流通备案申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2587765920","media":"国际金融报","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2587765920?lang=zh_cn&edition=full","pubTime":"2025-11-29 22:35","pubTimestamp":1764426956,"startTime":"0","endTime":"0","summary":"11月28日，派格生物医药-B(02565.HK)发布公告称，当日向中国证监会申请将20名股东持有的约26.35%未上市股份（1.017亿股）按一比一转换为H股并上市。尽管无需股东大会批准，但尚待监管审批。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202511293578339825.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511293578339825.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02565","BK1161"],"gpt_icon":0},{"id":"2586202061","title":"派格生物医药-B(02565)就申请建议实行H股全流通向中国证监会备案","url":"https://stock-news.laohu8.com/highlight/detail?id=2586202061","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586202061?lang=zh_cn&edition=full","pubTime":"2025-11-28 16:45","pubTimestamp":1764319505,"startTime":"0","endTime":"0","summary":"智通财经APP讯，派格生物医药-B(02565)发布公告，本公司已于2025年11月28日就按一比一的基准将本公司20名股东持有的合共1.02亿股未上市股份转换为本公司H股(占本公司于本公告日期已发行股份总数约26.35%)而向中国证监会提交申请。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1375064.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02565","BK1161","161726","399441"],"gpt_icon":0},{"id":"2586297590","title":"派格生物医药-B(02565.HK)高开逾7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586297590","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586297590?lang=zh_cn&edition=full","pubTime":"2025-11-27 09:44","pubTimestamp":1764207862,"startTime":"0","endTime":"0","summary":"每经AI快讯，派格生物医药-B(02565.HK)高开逾7%，截至发稿，涨7.03%，报70港元，成交额77万港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202511273576346796.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511273576346796.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["161726","399441","BK1161","02565"],"gpt_icon":0},{"id":"2586547062","title":"派格生物医药-B(02565)：基石投资者自愿延长禁售期","url":"https://stock-news.laohu8.com/highlight/detail?id=2586547062","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586547062?lang=zh_cn&edition=full","pubTime":"2025-11-26 20:40","pubTimestamp":1764160855,"startTime":"0","endTime":"0","summary":"智通财经APP讯，派格生物医药-B(02565)发布公告，近日，本公司接获益泽康瑞医药(香港)有限公司(基石投资者)的通知，基石投资者同意自原禁售期届满日期起至2025年12月31日不会以任何方式减持任何相关H股(禁售延长)。本公司认为，禁售期延长表明基石投资者基于本公司对推进技术方面的研发能力及在重大临床里程碑方面取得的重大进展，对本公司的未来前景充满信心。基石投资者亦将持续审阅本公司业绩，且或会基于实时发展及所实现的里程碑，考虑进一步延长禁售期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1374112.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["161726","02565","BK1161","399441"],"gpt_icon":0},{"id":"2586147218","title":"每日卖空追踪 | 派格生物医药-B 11月26日卖空量成交9500股，卖空比例为1.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586147218","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586147218?lang=zh_cn&edition=full","pubTime":"2025-11-26 16:30","pubTimestamp":1764145828,"startTime":"0","endTime":"0","summary":"派格生物医药-B北京时间11月26日，涨2.51%，卖空量成交9500股，较上一交易日增加58.33%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126163432951b4ba8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126163432951b4ba8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02565"],"gpt_icon":0},{"id":"2586499774","title":"每日卖空追踪 | 派格生物医药-B 11月24日卖空量成交4500股，卖空比例为0.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586499774","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586499774?lang=zh_cn&edition=full","pubTime":"2025-11-24 16:30","pubTimestamp":1763973030,"startTime":"0","endTime":"0","summary":"派格生物医药-B北京时间11月24日，涨3.56%，卖空量成交4500股，较上一交易日增加350%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124163423a70de0e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124163423a70de0e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02565"],"gpt_icon":0},{"id":"2585121009","title":"每日卖空追踪 | 派格生物医药-B 11月21日卖空量成交500股，卖空比例为0.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585121009","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585121009?lang=zh_cn&edition=full","pubTime":"2025-11-21 16:30","pubTimestamp":1763713831,"startTime":"0","endTime":"0","summary":"派格生物医药-B北京时间11月21日，涨1.12%，卖空量成交500股，较上一交易日减少97.5%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112116353795124fd1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112116353795124fd1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02565","BK1161"],"gpt_icon":0},{"id":"2585664601","title":"智通港股早知道 | 美国9月非农超预期 年内第三次降息恐难落地","url":"https://stock-news.laohu8.com/highlight/detail?id=2585664601","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585664601?lang=zh_cn&edition=full","pubTime":"2025-11-21 07:40","pubTimestamp":1763682015,"startTime":"0","endTime":"0","summary":"信达生物近期计划向国家药监局递交玛仕度肽9mg用于成人体重控制的上市申请。据新华财经，美国9月季调后非农就业人口新增11.9万人，预期5万人。经济数据断供终结，但美联储立场已生变，综合数据与美联储官员言论来看，年内第三次降息恐难落地。但由于多达7家竞标方参与竞拍，价格迅速攀升。截至2025年10月，该药品累计研发投入约34.95亿元。此次纳入有望加速其审评与上市进程，但新药上市仍存不确定性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"34d449692bfaa2931f7d79cc1f94e2b9","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1371856.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["SGCmain","518880","SImain","GCmain","GDX","DUST","IAU","159934","02696","HK0000165453.HKD","NUGT","BK1161","MGCmain","02565","SGUmain"],"gpt_icon":1},{"id":"2584920925","title":"每日卖空追踪 | 派格生物医药-B 11月19日卖空量成交8000股，卖空比例为1.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584920925","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584920925?lang=zh_cn&edition=full","pubTime":"2025-11-19 16:30","pubTimestamp":1763541028,"startTime":"0","endTime":"0","summary":"派格生物医药-B北京时间11月19日，跌0.92%，卖空量成交8000股，较上一交易日减少79.22%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119163440a4ac5133&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119163440a4ac5133&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02565","BK1161"],"gpt_icon":0},{"id":"2584972959","title":"强生30.5亿美元收购肿瘤新贵Halda；胃癌双抗Ziihera三期数据积极；派格生物GLP-1R激动剂“维培那肽”获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2584972959","media":"药财社","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584972959?lang=zh_cn&edition=full","pubTime":"2025-11-18 20:00","pubTimestamp":1763467253,"startTime":"0","endTime":"0","summary":"此次收购旨在进一步扩大强生在实体瘤及前列腺癌治疗领域的业务版图。2胃癌双抗Ziihera三期数据积极Jazz Pharmaceuticals与Zymeworks今日联合宣布，其3期HERIZON-GEA-01研究取得积极主要结果。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119001738a7024fb8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119001738a7024fb8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02565"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.pegbio.com","stockEarnings":[{"period":"1week","weight":0.0047},{"period":"1month","weight":0.0568},{"period":"3month","weight":0.236},{"period":"6month","weight":6.0806},{"period":"1year","weight":3.1122},{"period":"ytd","weight":3.1122}],"compareEarnings":[{"period":"1week","weight":-0.0028},{"period":"1month","weight":-0.0347},{"period":"3month","weight":-0.0405},{"period":"6month","weight":0.0824},{"period":"1year","weight":0.2928},{"period":"ytd","weight":0.2696}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"派格生物医药（杭州）股份有限公司是一家主要从事研究及开发慢性病创新疗法的中国公司。该公司的主要产品PB-119为自主开发、接近商业化阶段的长效胰高血糖素样肽1（GLP-1，一种降低血糖水平的肽类激素）受体激动剂。该公司的候选产品包括PB-718、PB-1902、PB-722、PB-2301和PB-2309。该公司的产品主要用于治疗2型糖尿病（T2DM）、肥胖症、非酒精性脂肪性肝炎（NASH）、阿片类药物引起的便秘（OIC，使用阿片类药物引起的胃肠道疾病）及先天性高胰岛素血症（一种罕见的内分泌疾病，患者持续出现低血糖症）等常见慢病及代谢疾病。","exchange":"SEHK","name":"派格生物医药-B","nameEN":"PEGBIO CO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"派格生物医药-B(02565)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供派格生物医药-B(02565)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"派格生物医药-B,02565,派格生物医药-B股票,派格生物医药-B股票老虎,派格生物医药-B股票老虎国际,派格生物医药-B行情,派格生物医药-B股票行情,派格生物医药-B股价,派格生物医药-B股市,派格生物医药-B股票价格,派格生物医药-B股票交易,派格生物医药-B股票购买,派格生物医药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"派格生物医药-B(02565)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供派格生物医药-B(02565)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}